← All organizations
University of Franche-Comté
Academic/Hospital
Also known as: Besancon University | Besancon University Hospital | Célia Turco | Centre Hospitalier Universitaire de Besançon | Centre Hospitalier Universitaire de Besancon | CH BESANCON | CHRU Besancon | CHU Besancon, France | CHU de Besancon | CHU Jean Minjoz-BESANCON | Nephrology, Dialysis and Renal Transplantation - CHU Besançon | University Hospital of Besancon
Highest phase reached
Phase 4
First clinical trial
Jan 1, 1998Last known activity
Nov 30, 2025
Timeline
1420s
- Jun 1, 1423
University of Franche-Comté— Founded
Drugs by trial phase (103 distinct, 75 trials)
Phase 4 (11 own, 0 via acquisition)
Phase 3 (42 own, 0 via acquisition)
Phase 2 (39 own, 0 via acquisition)
Phase 1 (6 own, 0 via acquisition)
Other trials (5 own, 0 via acquisition)
Indications
Studied for
- Acute Lung Injury
- Adenocarcinoma
- Aneurysm
- Anus Neoplasms
- Aortic Aneurysm
- Aortic Aneurysm, Abdominal
- Arthritis
- Arthritis, Rheumatoid
- Ascites
- Breast Neoplasms
- Carcinoma
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Renal Cell
- Carcinoma, Squamous Cell
- Cardiovascular Diseases
- Colitis
- Colitis, Ulcerative
- Colorectal Neoplasms
- Communicable Diseases
- Diabetes Mellitus
- Disease Progression
- Ear Neoplasms
- Esophageal Neoplasms
- Fibrosis
- Forearm Injuries
- Glioblastoma
- Graft vs Host Disease
- Hemiplegia
- Hepatitis C
- Hyperglycemia
- Infarction
- Infections
- Intracranial Hypertension
- Kidney Neoplasms
- Leukemia
- Leukemia, Lymphoid
- Lung Diseases
- Lung Diseases, Interstitial
- Lung Diseases, Obstructive
- Lung Neoplasms
- Multiple Myeloma
- Multiple Sclerosis
- Muscle Spasticity
- Myocardial Infarction
- Neoplasm Metastasis
- Neoplasms
- Neoplasms, Plasma Cell
- Neuroendocrine Tumors
- Penile Neoplasms
- Peritonitis
- Pneumonia
- Pneumonia, Ventilator-Associated
- Precursor Cell Lymphoblastic Leukemia-Lymphoma
- Pulmonary Disease, Chronic Obstructive
- Recurrence
- Respiratory Distress Syndrome
- Respiratory Distress Syndrome, Newborn
- Sclerosis
- Shock
- Shock, Septic
- Squamous Cell Carcinoma of Head and Neck
- Stomach Neoplasms
- Stroke
- Syndrome
- Ulcer
- Urinary Tract Infections
- Urticaria
- Vulvar Vestibulitis
- Vulvodynia
Recent trials (50)
- NCT07067801Lead sponsorPhase 3Nov 30, 2025
- NCT07036380Lead sponsorPhase 2Jun 30, 2025
- NCT06892951CollaboratorPhase 1/Phase 2Jun 30, 2025
- NCT06744400Lead sponsorPhase 1Jan 15, 2025
- NCT06642844CollaboratorPhase 3Oct 30, 2024
- NCT06425133Lead sponsorPhase 2Sep 30, 2024
- NCT05462613Lead sponsorPhase 2/Phase 3Nov 30, 2022
- NCT05528952Lead sponsorPhase 2Sep 27, 2022
- NCT05168839Lead sponsorPhase 3Aug 1, 2022
- NCT05241561Lead sponsorPhase 2Jun 30, 2022
- NCT04990349Lead sponsorPhase 3Oct 1, 2021
- NCT04969133Lead sponsorN/AJul 30, 2021
- NCT04769687Lead sponsorPhase 2Nov 21, 2020
- NCT04534218Lead sponsorPhase 2Sep 30, 2020
- NCT04488874Lead sponsorPhase 3Sep 29, 2020
Details
- Founded
- Besancon, FR Jun 1, 1423
- Last known activity
- Nov 30, 2025